Feb 22026 How Liso-Cel Is Shifting the Treatment Paradigm of Marginal Zone Lymphoma Marginal zone lymphoma treatment evolves with promising CAR T-cell therapies, addressing unmet needs in aggressive cases and improving patient outcomes.
